“…The expression of C/EBPR is high in terminally differentiated hepatocytes, but low in dedifferentiated liver tissue, such as in fetal liver (Birkenmeier et al, 1989), in liver tumor cells (Friedman et al, 1989), in primary cultured hepatocytes (Mischoulon et al, 1992), and in the regenerating liver (see above). In contrast, β 2 AR activation inhibits glycogen synthase and leads to glycogen breakdown, and β 2 AR expression is very low in the differentiated, adult rat liver, but high in fetal liver (Blair et al, 1979;Baeyens & Cornett, 1993), in liver tumors (Bevilacqua et al, 1991), in primary cultured hepatocytes (Nakamura et al, 1983;Refsnes et al, 1983), and in the regenerating liver (see above). This striking, inverse relationship makes it very likely that C/EBPR is a negative regulator of hepatic β 2 AR expression in the rat in vivo.…”